Objective: The objective of this study was to assess suitability of dual-time-point 18F-FDG [(18F)-fluoro-2-deoxyglucose]-PET imaging for differentiating between malignant and benign pulmonary lesions, whose size and maximal standardized uptake values (SUVs) are greater than 10 mm and 2.5, respectively.
Methods: A total of 38 patients, 27 with malignant lesions (n = 30), and 11 with benign lesions (n = 22), were investigated by performing two static acquisitions started at mean times t = 79 and t = 158 min after the tracer injection. A model analysis involving tissue 18F-FDG uptake and release has been developed and applied.
Results: Malignant lesions showed a SUV increase between the two acquisitions for 27 of 30 lesions, and a SUV decrease or constancy for the other three. Benign lesions showed a SUV increase in 19 of 22 lesions, and a SUV decrease in three (both increase and decrease were observed for multiple benign lesions in two patients).
Conclusion: It is recommended that dual-time-point 18F-FDG-PET imaging is not indicated to differentiate between malignant and benign pulmonary lesions, whose size and maximal SUV are greater than 10 mm and 2.5, respectively. Furthermore, a model analysis suggests that the variation in SUV observed between early and delayed scans may be explained by different values of the 18F-FDG release/uptake ratio.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MNM.0b013e32832bdcac | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ga-DOTA-FAPI-04 and F-FDG PET/CT: a head-to-head comparison for peritoneal carcinomatosis diagnostic accuracy.
Abdom Radiol (NY)
January 2025
Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050011, Hebei, China.
Purpose: The study aimed to compare the diagnostic accuracy of Ga-DOTA-FAPI-04 (Ga-FAPI) and F-FDG PET/CT for peritoneal carcinomatosis (PC) in patients with various types of cancer.
Methods: The study enrolled 113 patients with suspected peritoneal malignancy, each of whom underwent Ga-FAPI and F-FDG PET/CT scans. Lesions in all patients were confirmed through pathology or radiological follow-up.
The SwiftScan step-and-shoot continuous mode improves SPECT scanning efficiency: a preliminary phantom and clinical test.
EJNMMI Phys
January 2025
Department of Nuclear Medicine, Lanzhou University Second Hospital, Lanzhou, 730030, China.
Purpose: The aim of the study was to investigate the value of SwiftScan Step-and-Shoot Continuous (SSC) scanning mode in enhancing image quality and to explore appropriate scanning parameters for reducing scan time.
Methods: This study was composed of a phantom study and two clinical tests. The differences in visual image quality scores, coefficient of variance (COV) of the background, image signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and recovery coefficient (RC) of the sphere were compared between SSC mode and traditional Step-and-Shoot (SS) mode in the phantom study.
Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [Ga]Ga/[Lu]Lu-NYM032 for theranostic use in prostate cancer.
Eur J Nucl Med Mol Imaging
January 2025
Department of Nuclear Medicine, Affiliated Hospital of Jiangnan University, No. 1000, Hefeng Road, Wuxi, Jiangsu Province, 214000, China.
Article Synopsis
- A new theranostic radiopharmaceutical, [Ga]Ga/[Lu]Lu-NYM032, was developed to target prostate-specific membrane antigen (PSMA) for diagnosing and treating prostate cancer (PCa).
- In preclinical studies, [Ga]Ga-NYM032 showed high specificity and uptake in PSMA-positive tumors, outperforming a comparator in detecting bone and lymph node metastases.
- The therapeutic component, [Lu]Lu-NYM032, demonstrated effectiveness in inhibiting tumor growth in animal models, with larger doses leading to significantly smaller tumor sizes.
[F]FDG PET/CT volumetric biomarkers for non-invasive prediction of HER2 expression in breast cancer patients.
Asia Ocean J Nucl Med Biol
January 2025
Nuclear Medicine Unit, National Cancer Institute (NCI), Cairo University, Cairo, Egypt.
Objectives: to investigate the capability of F-fluorodeoxyglucose positron emission tomography/computed tomography ([F]-FDG PET/CT) derived volumetric parameters to predict human epidermal growth factor receptor 2 (HER2) status in breast cancer patients.
Methods: retrospective study enrolled 47 female patients with breast cancer. All patients had pretreatment [F]-FDG PET/CT.
Improvement of image quality for small lesion sizes in F-FDG prone breast silicon photomultiplier-based PET/CT imaging.
Asia Ocean J Nucl Med Biol
January 2025
Department of Radiology, Faculty of Medicine, Shimane University, Izumo, Japan.
Objectives: We investigated image quality and standardized uptake values (SUVs) for different lesion sizes using clinical data generated by F-FDG-prone breast silicon photomultiplier (SiPM)-based positron emission tomography/computed tomography (PET/CT).
Methods: We evaluated the effect of point-spread function (PSF) modeling and Gaussian filtering (Gau) and determined the optimal reconstruction conditions. We compared the signal-to-noise ratio (SNR), contrast, %coefficient of variation (%CV), SUV, and Likert scale score between ordered-subset expectation maximization (OSEM) time-of-flight (TOF) and OSEM+TOF+PSF in phantom and clinical studies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!